Introduction: The initial global response to the SARS-CoV-2 pandemic focused on adults as adolescents mainly had subclinical infections. Adolescents, however, could transmit the virus and hence be a risk to the elderly, young children and immunocompromised. Adolescents are also at risk of long-term complications. This study sought to determine the prevalence of antibodies to SARS-CoV-2 among adolescents in Southern Nigeria, and to determine the association between SARS-CoV-2 seropositivity and age, gender, socioeconomic class, school type and nutritional status. Methods: This descriptive cross-sectional study was carried out in Edo state of southern Nigeria. We recruited 270 in-school adolescents aged 10 - 19 years. A WHO-adapted, pre-tested questionnaire was used to obtain data on participant history and risk factors. The questionnaire was interviewer-administered. Adolescents whose parents gave consent were recruited through a multi-stage randomized sampling method. Capillary blood for the assay was collected and analysed using a lateral-flow immunoassay device. The primary outcome was serostatus of the study. The positive predictors of serostatus were finally determined using a multiple logistics regression model. Statistical significance was set at p < 0.05. Results: The seroprevalence of SARS-CoV-2 was 45.9%. IgM antibodies were found in 5.6% of participants. Older adolescents had higher seropositivity rates than younger adolescents (χ2 = 8.101, p= 0.017). There was no association between gender and seropositivity. Adolescents in public schools were more likely to be seropositive than those in private schools (χ2= 25.242, p= 0.001). A higher seroprevalence was noticed among study participants in the lower socioeconomic class (x2 = 6.928, p = 0.031), and those in overcrowded classes. (χ2 = 79.303, p = 0.001). Conclusion: This study showed a high seroprevalence of SARS-CoV-2 among in-school adolescents. Behavioural change communication on SARS-CoV-2, vaccination of adolescents, and standardization
References
[1]
Yuki, K., Fujiogi, M. and Koutsogiannaki, S. (2020) COVID-19 Pathophysiology: A Review. Clinical Immunology, 215, Article ID: 108427. https://doi.org/10.1016/j.clim.2020.108427
[2]
Elimian, K.O., Ochu, C.L., Ilori, E., Oladejo, J., Igumbor, E., Steinhardt, L., et al. (2020) Descriptive Epidemiology of Coronavirus Disease 2019 in Nigeria, 27 February-6 June 2020. Epidemiology and Infection, 148, e208. https://doi.org/10.1017/S095026882000206X
[3]
UNICEF (2022) COVID-19 Confirmed Cases and Deaths—UNICEF DATA. https://data.unicef.org/resources/covid-19-confirmed-cases-and-deaths-dashboard/
[4]
Park, Y.J., Choe, Y.J., Park, O., Park, S.Y., Kim, Y.M., Kim, J., et al. (2020) Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerging Infectious Diseases, 26, 2465-2468. https://doi.org/10.3201/eid2610.201315
[5]
NCDC (2023) Nigeria Centre for Disease Control and Prevention Protecting the Health of Nigerians. https://ncdc.gov.ng/news/505/official-statement-to-the-news-on-covid-19-resurgence-in-benue-state
[6]
World Health Organization (2021) Advice on the Use of Point-of-Care Immunodiagnostic Tests for COVID-19. https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19
[7]
UNICEF (2022) Child Mortality and COVID-19. UNICEF Data. https://data.unicef.org/topic/child-survival/covid-19/
[8]
Roberts, J.E., Campbell, J.I., Gauvreau, K., Lamb, G.S., Newburger, J., Son, M.B., et al. (2022) Differentiating Multisystem Inflammatory Syndrome in Children: A Single-Centre Retrospective Cohort Study. Archives of Disease in Childhood, 107, e3. https://adc.bmj.com/content/107/3/e3 https://doi.org/10.1136/archdischild-2021-322290
[9]
Moore, J.T., Ricaldi, J.N., Rose, C.E., Fuld, J., Parise, M., Kang, G.J., et al. (2020) Disparities in Incidence of COVID-19 among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots during June 5-18, 2020—22 States, February-June 2020. Morbidity and Mortality Weekly Report, 69, 1122-1126. https://doi.org/10.1136/archdischild-2021-322290
[10]
Danae, B., Allison, M. and Claire, M. (2020) CDC: 74% of Children Who Died from SARS-CoV-2 Are Hispanic, Black. AAP News. https://publications.aap.org/aapnews/news/8093/CDC-74-of-children-who-died-from-SARS-CoV-2-are?searchresult=1&utm_source=TrendMD&utm_medium=TrendMD&utm_campaign=AAPNews_TrendMD_0
[11]
World Health Organization (2020) Population-Based Age-Stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection. https://iris.who.int/handle/10665/331656
[12]
WHO Regional Office for Europe (2020) COVID-19 Snapshot Monitoring (COSMO Standard): Monitoring Knowledge, Risk Perceptions, Preventive Behaviours, and Public Trust in the Current Coronavirus Outbreak—WHO Standard Protocol. https://psycharchives.org/en/item/62216bdb-69fa-44e7-92b4-8438b3817341
[13]
Yetunderonke, O. (2015) A Study of Housing Adequacy of Multi-Habited Houses in a Typical Nigerian Town. International Journal of Advanced and Multidisciplinary Social Science,1, 7-12. http://journal.sapub.org/jamss
[14]
World Health Organization (2018) WHO Housing and Health Guidelines. https://www.who.int/publications/i/item/9789241550376
[15]
UNESCO (2006) UNESCO IBE—World Data on Education, 6th Edition. https://unesdoc.unesco.org/ark:/48223/pf0000379618
[16]
WHO (2014) Adolescence: A Period Needing Special Attention—Age-Not-the-Whole-Story. https://apps.who.int/adolescent/second-decade/section2/page2/age-not-the-whole-story.html
[17]
Kolawole, O.M., Tomori, O., Agbonlahor, D., Ekanem, E., Bakare, R., Abdulsalam, N., et al. (2022) SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria. JAMA Network Open, 5, e2236053. https://doi.org/10.1001/jamanetworkopen.2022.36053
[18]
Okpala, O.V., Dim, C.C., Ugwu, C.I., Onyemaechi, S., Uchebo, O., Chukwulobelu, U., et al. (2021) Population Seroprevalence of SARS-CoV-2 Antibodies in Anambra State, South-East, Nigeria. International Journal of Infectious Diseases, 110, 171-178. https://doi.org/10.1016/j.ijid.2021.07.040
[19]
Cennimo, J.D., Bergman, S.J. and Olsen, K.M. (2022) Coronavirus Disease 2019 (COVID-19): Practice Essentials, Background, Route of Transmission. https://emedicine.medscape.com/article/2500114-overview
[20]
Steinberg, L. (2008) A Social Neuroscience Perspective on Adolescent Risk-Taking. Developmental Review, 28, 78-106. https://doi.org/10.1016/j.dr.2007.08.002
[21]
Audu, R.A., Stafford, K.A., Steinhardt, L., Musa, Z.A., Iriemenam, N., Ilori, E., et al. (2022) Seroprevalence of SARS-CoV-2 in Four States of Nigeria in October 2020: A Population-Based Household Survey. PLOS Global Public Health, 2, e0000363. https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0000363 https://doi.org/10.1371/journal.pgph.0000363
[22]
Olaleye, D., Aminu, M., Olusola, B., Segun, T., Faneye, A., Opayele, A., et al. (2022) High Seroprevalence of SARS-COV-2 Antibody before Covid-19 Vaccination in Nigerian Communities. International Archives of Public Health and Community Medicine, 6, Article 83. https://doi.org/10.23937/2643-4512/1710083
[23]
Nwosu, K., Fokam, J., Wanda, F., Mama, L., Orel, E., Ray, N., et al. (2021) SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon. Nature Communications, 12, Article No. 5851. https://doi.org/10.1038/s41467-021-25946-0
[24]
Karachaliou, M., Moncunill, G., Espinosa, A., Castaño-Vinyals, G., Jiménez, A., Vidal, M., et al. (2021) Infection Induced SARS-CoV-2 Seroprevalence and Heterogeneity of Antibody Responses in a General Population Cohort Study in Catalonia Spain. Scientific Reports, 11, Article No. 21571. https://doi.org/10.1038/s41598-021-00807-4
[25]
Indenbaum, V., Lustig, Y., Mendelson, E., Hershkovitz, Y., Glatman-Freedman, A., Keinan-Boker, L., et al. (2021) Under-Diagnosis of SARS-CoV-2 Infections among Children Aged 0-15 Years, a Nationwide Seroprevalence Study, Israel, January 2020 to March 2021. Eurosurveillance, 26, Article ID: 2101040. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.48.2101040 https://doi.org/10.2807/1560-7917.ES.2021.26.48.2101040
[26]
Ferreira, M.U., Giacomini, I., Sato, P.M., Lourenço, B.H., Nicolete, V.C., Buss, L.F., et al. (2022) SARS-CoV-2 Seropositivity and COVID-19 among 5 Years-Old Amazonian Children and Their Association with Poverty and Food Insecurity. PLOS Neglected Tropical Diseases, 16, e0010580. https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010580 https://doi.org/10.1371/journal.pntd.0010580
